Xiujie Sheng
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 5
- Cancer, Hypoxia, and Metabolism 2
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 2
- Reproductive Medicine top 10%
-
- RNA modifications and cancer 5
- Circular RNAs in diseases 3
- Epigenetics and DNA Methylation 2
-
- Cervical Cancer and HPV Research 4
- Co-authors
- Shuo ChenYang ZhaoZhi‐Hong ZongJuan LiuBohong CenYuanli HeShaohua DuJuan Li
- Journals
- Journal of Clinical Oncology (1 paper)Scientific Reports (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiujie Sheng
20 papers receiving 445 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 227
- Obstetrics and Gynecology 56
- Reproductive Medicine 44
- Molecular Biology 292
- Immunology 48
Countries citing papers authored by Xiujie Sheng
This map shows the geographic impact of Xiujie Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiujie Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiujie Sheng more than expected).
Fields of papers citing papers by Xiujie Sheng
This network shows the impact of papers produced by Xiujie Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiujie Sheng. The network helps show where Xiujie Sheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiujie Sheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 11 | |
| 8 | 2020 | 7 | |
| 9 | 2020 | 47 | |
| 10 | 2019 | 60 | |
| 11 | 2019 | 44 | |
| 12 | 2019 | 20 | |
| 13 | 2018 | 36 | |
| 14 | 2017 | 20 | |
| 15 | 2015 | 84 | |
| 16 | 2014 | 27 | |
| 17 | 2014 | 71 | |
| 18 | [The lowest dosages of mifepristone and misoprostol to terminate ultra-early pregnancy]. | 2012 | 7 |
| 19 | Expression of p27 Protein in Endometrial Carcinoma | 2006 | 0 |
| 20 | 2004 | 2 |
About Xiujie Sheng
Xiujie Sheng is a scholar working on Cancer Research, Obstetrics and Gynecology and Reproductive Medicine, having authored 24 papers that have together received 454 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers), Cervical Cancer and HPV Research (4 papers), Circular RNAs in diseases (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (227 citations), Obstetrics and Gynecology (56 citations) and Reproductive Medicine (44 citations). Xiujie Sheng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shuo Chen, Yang Zhao, Zhi‐Hong Zong, Juan Liu, Bohong Cen, Yuanli He, Shaohua Du, Juan Li, Yuping Du and Yanqing Zhou. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.